Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients

Intensive Care Medicine

Volumn 25, Issue 10, 1999, Pages 1100-1104

  Boereboom, F T J ^a   Ververs, F F T ^a   Blankestijn, P J ^a   Savelkoul, T J F ^a   Van Dijk, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CVVHF; Intensive care; Vancomycin

Indexed keywords

POLYACRYLONITRILE; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD FILTER; CASE REPORT; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HEMOFILTRATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; SEPTIC SHOCK; ULTRAFILTRATION;

EID: 0032694744     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340051018     Document Type: Article

References (16)

1. 1. Golpner TA, Wedel SK, Kaplan AA, Saad AM, Donta ST, Paganini EP (1985) Drug removal during continuous arteriovenous haemofiltration: theory and clinical observations. Artif Organs 8: 307-312
2. 2. Vincent HH, Vos MC, Akcahuseyin E, Goessens WHF, van Duyl WA, Schalenkamp MADH (1993) Drug clearance by continuous haemodiafiltration. Blood Purif 3: 341-349
3. 3. Sandford JP, Gilbert DN, Gerberding JL, Sande MA (1994) Guide to antimicrobial therapy. 107-111
4. 4. Keller E (1996) Pharmacokinetics during continous renal replacement therapy. Artif Organs 19: 113-117
5. 5. Bresolle F, Kinowski J-M, de la Coussaye JE, Wynn N, Eledjam J-J, Galtier M (1994) Clinical pharmacokinetics during continuous haemofiltration. Clin Pharmacokinet 26: 457-471
6. 6. Armendariz E, Chelluri L, Ptachcinski R (1990) Pharmacokinetics of amikacin during continuous veno-venous haemofiltration. Crit Care Med 18: 675-676
7. 7. Davies SP, Azadian BS, Kox WJ, Brown EA (1992) Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis. Nephrol Dial Transplant 7: 848-854
8. 8. Santré C, Leory O, Simon M, Georges H, Guery B, Beuscart C, Beaucaire G (1993) Pharmacokinetics of vancomycin during continuous haemodiafiltration. Intensive Care Med 19: 347-350
9. 9. Lindsay CA, Bawdon R, Quigley R (1996) Clearance of ticacillin-clavulanic acid by continuous venovenous haemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation. Pharmacotherapy 16: 458-462
10. 10. Kroh U, Hofmann W, Dehne M, El Abed K, Lennatz H (1989) Dosisanpassung von Pharmaca während kontinuierlicher Hämofiltration. Anaesthesist 38: 225-232
11. 11. Tegeder I, Bremer F, Oelkers R, Schobel H, Schüttler J, Brune K, Geissligner G (1997) Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous haemofiltration. Antimicrob Agents Chemother 41: 2640-2645
12. 12. vander Werf TS, Mulder POM, Zijlstra JG, Uges DRA, Stegeman CA (1997) Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous haemofiltration. Intensive Care Med 23: 873-877
13. 13. Valtonen M, Tiula E, Neuvonen PJ (1997) Effect of continous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure. J Antimicrob Chemother 40: 695-700
14. 14. Joy MS, Matzke GR, Frye RF, Palevsky PM (1998) Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous haemodialysis. Am J Kidney Dis 31: 1019-1027
15. 15. Pond SM (1991) Extra-corporeal techniques in the management of poisoned patients. Med J Aust 154: 617-622
16. 16. Macias WL, Mueller BA, Scarim SK (1991) Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance. Clin Pharmacol Ther 50: 688-694